Fast Pass: 47

​It’s time for another Fast Pass.

​The administration change here in the U.S. has presented challenges anew for all communicators, but especially for us in biopharma — with the pending RFK Jr. confirmation, HHS comms freeze, and DEI rollbacks.

​Beyond “just” this, there have been abundant heartbreak and tragedy from coast to coast, from devastating fires to this week’s shocking plane collision.

​Last fall, we gathered our members for our first ad hoc open forum, or Fast Pass. Then, in particular, the need for community was immediately clear to us.

​As the longest-ever January finally draws to a close, this is another moment in time calling for us to lean on each other.